Ovarian Cancer
Our major research goal is to identify new ways to diagnose women
with early stage curable ovarian cancer. To this end, we use a
combination of genetic and epigenetic approaches to understand the
molecular changes involved in the development of ovarian cancer.
Together with the Epigenetics Group, our current primary focus is the
identification of a panel of methylated genes that may have potential
as diagnostic markers for early stage ovarian cancer. These markers
will likely include genes that control the development of ovarian
cancer, and therefore may also include potential novel therapeutic
targets for treatment of advanced disease.
Staff
| Research Officer Celine Montavon |
Research Officer Kristina Warton |
Maria Gonzales |
Kate Patterson |
| PhD Student Gabriella Matta |
PhD Student Brian Gloss |
| Data Entry
Clerk Jacqueline Gerharty |
